UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
______________________
Date of Report (Date of earliest event reported): October 17, 2016
MEDIFAST, INC.
(Exact name of registrant as specified in its charter)
|
Delaware (State or other jurisdiction of incorporation) |
001-31573 (Commission File Number) |
13-3714405 (I.R.S. Employer Identification No.) |
| 3600 Crondall Lane, Owings Mills, Maryland 21117 | ||
| (Address of Principal Executive Offices) (Zip Code) | ||
| Registrant's telephone number, including area code: (410) 581-8042 | ||
|
N/A (Former Name or Former Address, if Changed Since Last Report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 7.01. | Regulation FD Disclosure. |
On October 17, 2016, Medifast, Inc. (the “Company”) will participate in several investor presentations in San Francisco, California. The materials attached hereto as Exhibit 99.1 will be presented at the meetings. The presentation is also available on the Company’s website.
The information being furnished pursuant to Item 7.01 of this Current Report on Form 8-K and contained in Exhibit 99.1 shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
| Item 9.01. | Financial Statements and Exhibits |
| (d) | Exhibits |
| Exhibit No. |
Description |
| 99.1 | Investor Presentation dated October 17, 2016. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MEDIFAST, INC. | ||
| By: | /s/ Jason L. Groves | |
| Name: | Jason L. Groves, Esq. | |
| Title: | Executive Vice President, General | |
| Counsel & Corporate Secretary | ||
Date: October 17, 2016
Exhibit Index
| Exhibit No. |
Description |
| 99.1 | Investor Presentation dated October 17, 2016. |